| 摘要 |
<p>This invention comprises a low solubility salt of moxonidine and pharmaceutical formulations, containing a low solubility moxonidine salt, for the sustained release of moxonidine. The invention further discloses methods for prophylactically or therapeutically treating hypertension or left ventricular hypertrophy comprising with the sustained release, low solubility moxonidine pharmaceutical formulation.</p> |
